🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to draw blood from patients with well-defined atop...
Status
Completed
Location
Fraunhofer ITEM im CRC
Start Date
2018-08-16
Trial ID
NCT03665701
Treatments Being Tested
This was an exploratory, randomized, subject- and investigator-blind, place...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-05-21
Trial ID
NCT03810183
Laropiprant (LRP; Merck \& Co., Inc, Whitehouse Station, NJ, USA) is a pote...
Status
Terminated
Location
Leviev Heart Center, Sheba Medical Center
Start Date
2010-07
Trial ID
NCT01052311
Treatments Being Tested
Prostaglandins are important signaling compounds formed from arachidonic ac...
Status
Enrolling By Invitation
Location
Vanderbilt University
Start Date
2020-08-15
Trial ID
NCT04464070
The aim of this study is to assess the effectiveness of a CRTH2 receptor an...
Status
Completed
Location
St Mary's Hospital
Start Date
2015-01
Trial ID
NCT02660489
Treatments Being Tested
This study will assess the safety and efficacy of QAW039 when added to curr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01545726
The purpose of this study is to evaluate the efficacy and safety of Lertal®...
Status
Completed
Location
Fondazione IRCCS Policlinico San Matteo
Start Date
2017-09-15
Trial ID
NCT03365648
Treatments Being Tested
Prostaglandin D2 (PGD2) has anti-inflammatory activity, particularly via Li...
Status
Recruiting
Location
CHU de Nimes
Start Date
2025-06-25
Trial ID
NCT06864494
Treatments Being Tested
The first-in-man study are designed as below to assess safety, tolerability...
Status
Unknown
Location
Linear Clinical Research Unit
Start Date
2015-03
Trial ID
NCT02397005
Treatments Being Tested
This is an exploratory, randomized, subject- and investigator-blinded, plac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-10-15
Trial ID
NCT03989635
Treatments Being Tested